Diagnostic value of immunopathology in malignant pleural tumors

Diagnostic value of immunopathology in malignant pleural tumors

Background Immunohistochemistry (IHC) plays a basic role in the diagnosis and differentiation of malignant pleural tumors (MPT). Objective To recognize histological types of MPT to enhance selection of IHC markers for final diagnosis and to simplify the panel of antibodies required. Patients and m...

Full description

Bibliographic Details
Main Authors:	Taghreed S Farag, Abeer S Farag, Hanan A Oreiby
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2018-01-01
Series:	Egyptian Journal of Chest Disease and Tuberculosis
Subjects:	Ber-EP4 calretinin; carcinoembryonic antigen Hector Battifora mesothelial-1 malignant mesothelial pleural tumors malignant pleural tumors
Online Access:	http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2018;volume=67;issue=4;spage=440;epage=450;aulast=Farag

Similar Items

Value of cytokeratin-19, Hector Battifora mesothelial-1 and galectin-3 immunostaining in the diagnosis of thyroid neoplasms
by: Rajasekhar Sanuvada, et al.
Published: (2018-04-01)

Evaluation of the Sensitivity and Specificity of Immunohistochemical Markers in the Differential Diagnosis of Effusion Cytology
by: Zahraa Mohammed Yahya, et al.
Published: (2013-11-01)

Endothelin-1 Induces Mesothelial Mesenchymal Transition and Correlates with Pleural Fibrosis in Tuberculous Pleural Effusions
by: Zhung-Han Wu, et al.
Published: (2019-03-01)

The Pleural Mesothelium in Development and Disease
by: Hitesh eBatra, et al.
Published: (2014-08-01)

Risk Factors for High Mesothelial Cell Counts in HIV-negative Patients With Tuberculous Pleural Effusion
by: Shih-Lung Cheng, et al.
Published: (2010-06-01)

Thrombin Upregulates PAI-1 and Mesothelial–Mesenchymal Transition Through PAR-1 and Contributes to Tuberculous Pleural Fibrosis
by: Cheng-Ying Hsieh, et al.
Published: (2019-10-01)

In Vitro Characterization of Cisplatin and Pemetrexed Effects in Malignant Pleural Mesothelioma 3D Culture Phenotypes
by: Eleftherios D. Papazoglou, et al.
Published: (2019-09-01)

Empyema thoracis: new insights into an old disease
by: Y.C.G. Lee, et al.
Published: (2010-09-01)

Antígeno carcinoembrionário no diagnóstico diferencial dos derrames pleurais
by: Miguel Angelo Martins de Castro Junior, et al.

Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion
by: Yimin Tang, et al.
Published: (2019-01-01)

Pleural effusion revealing a ruptured mediastinal mesothelial cyst
by: Ahmed Ben Saad, et al.
Published: (2020-11-01)

Pleural epithelioid hemangioendothelioma mimicking pleural empyema: A case report
by: Katrine Fjaellegaard, et al.
Published: (2020-01-01)

The clinical utility of joined detection of cancer ratio, cancer ratio plus, Interferon gamma (IFN-ϒ) & Carcinoembryonic antigen (CEA) in differentiating lymphocytic pleural effusions
by: Dalia E. ElSharawy, et al.
Published: (2020-05-01)

Free-Floating Mesothelial Cells in Pleural Fluid After Lung Surgery
by: Arne Kienzle, et al.
Published: (2018-04-01)

Ancillary Diagnostic Investigations in Malignant Pleural Mesothelioma
by: Alex Dipper, et al.
Published: (2021-06-01)

Primary human mesothelial cell culture in the evaluation of the inflammatory response to different sclerosing agents used for pleurodesis
by: Michal Mierzejewski, et al.
Published: (2021-04-01)

Clinical Value of Tumor Markers for Determining Cause of Pleural Effusion
by: Yan Gu, et al.
Published: (2016-01-01)

HDAC Inhibitor Abrogates LTA−Induced PAI-1 Expression in Pleural Mesothelial Cells and Attenuates Experimental Pleural Fibrosis
by: Wei-Lin Chen, et al.
Published: (2021-06-01)

Primary pleural primitive neuroendocrine tumor: A rare entity
by: Mayuri Johari, et al.
Published: (2016-01-01)

Malignant Pleural Mesothelioma: Spotlight on Recent Advances in Diagnosis and Treatment
by: Aline N. Zouk, et al.
Published: (2017-10-01)

Interleukin‐5‐producing malignant pleural mesothelioma with eosinophilic pleural effusion
by: Eiji Takeuchi, et al.
Published: (2020-10-01)

Accuracy of closed pleural biopsy in the diagnosis of malignant pleural effusion
by: Renata Báez-Saldaña, et al.

Diagnostic value of calprotectin in differentiation between benign and malignant pleural effusion
by: Omar M. Mohammed, et al.
Published: (2019-07-01)

Management of Pleural Effusion Secondary to Malignant Mesothelioma
by: Valeria Musso, et al.
Published: (2021-09-01)

Diagnostic utility of pleural fluid and serum markers in differentiation between malignant and non-malignant pleural effusions
by: Korczynski P, et al.
Published: (2009-12-01)

Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, and cytokeratin 19 fragments in patients with effusion from nonsmall cell lung cancer
by: Sushil Kumar Sharma, et al.
Published: (2015-01-01)

Use of a small bore pleural catheter in the managemen of patients with malignant pleural effusion
by: Mohamed A. Farrag, et al.
Published: (2017-07-01)

Pleural Space Elastance and Its Relation to Success Rates of Pleurodesis in Malignant Pleural Effusion
by: Hossam Hosny Masoud, et al.
Published: (2021-01-01)

Closed Pleural Biopsy is Still Useful in the Evaluation of Malignant Pleural Effusion
by: Somnath Bhattacharya, et al.
Published: (2012-01-01)

A Case of Pulmonary Embolism with Sarcomatoid Malignant Pleural Mesothelioma with Long-Term Pleural Effusion
by: Gu R, et al.
Published: (2021-07-01)

Diagnostic Outcome of Open Pleural Biopsy
by: Hafiza Habiba Asma, et al.
Published: (2020-09-01)

Differentiation Between the Malignant Mesothelioma of Pleura and Pleural Metastasis with Contrast Enhanced CT, Is It Possible?
by: Krittachat Butnian, et al.
Published: (2021-09-01)

Differentiation Between the Malignant Mesothelioma of Pleura and Pleural Metastasis with Contrast Enhanced CT, Is It Possible?
by: Krittachat Butnian, et al.
Published: (2021-08-01)

A novel pleural-bladder pump for the management of recurrent malignant pleural effusions: a feasibility animal study
by: S. Laroumagne, et al.
Published: (2020-07-01)

Treatment of malignant pleural effusions: the case for localized immunotherapy
by: Albert D. Donnenberg, et al.
Published: (2019-04-01)

Diagnostic role of interleukin -33 in the differentiation of pleural effusions especially tuberculous and malignant effusions
by: Abdel-sadek Hamed Al-aarag, et al.
Published: (2019-06-01)

Pleural diffuse mesothelial lesions: A challenge for pathologists
by: Antonio Ieni, et al.
Published: (2018-06-01)

Evaluation of pleural fluid YKL-40 as a marker of malignant pleural effusion
by: Adel Attia, et al.
Published: (2015-04-01)

Approach to malignant pleural effusions: Role of pleural manometry exemplified by case scenarios
by: Irfan Ismail Ayub
Published: (2019-01-01)

Comparison between Cytologic and Pathologic Diagnostic Results of Malignant Pleural Effusion in Patients Admitted to Shahid Sadughi Hospital during 2004-2013
by: M Moghimi, et al.
Published: (2015-10-01)